OPKO Health (OPK) Director Robert Scott Fishel Acquires 10,000 Shares

OPKO Health (NASDAQ:OPK) Director Robert Scott Fishel acquired 10,000 shares of OPKO Health stock in a transaction on Friday, April 13th. The shares were purchased at an average cost of $3.02 per share, for a total transaction of $30,200.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Shares of OPKO Health stock opened at $2.99 on Monday. The firm has a market cap of $1,672.83, a price-to-earnings ratio of -10.31 and a beta of 1.56. OPKO Health has a 52 week low of $2.66 and a 52 week high of $7.90. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.14 and a quick ratio of 0.98.

How to Become a New Pot Stock Millionaire

OPKO Health (NASDAQ:OPK) last issued its earnings results on Thursday, March 1st. The biotechnology company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.04). The business had revenue of $193.70 million for the quarter, compared to the consensus estimate of $307.44 million. OPKO Health had a negative net margin of 28.93% and a negative return on equity of 7.87%. sell-side analysts forecast that OPKO Health will post -0.48 EPS for the current year.

Several institutional investors have recently modified their holdings of the business. The Manufacturers Life Insurance Company increased its position in shares of OPKO Health by 7.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,535 shares of the biotechnology company’s stock valued at $149,000 after buying an additional 1,657 shares in the last quarter. Ellington Management Group LLC bought a new stake in shares of OPKO Health in the 4th quarter valued at $112,000. State of Alaska Department of Revenue bought a new stake in shares of OPKO Health in the 4th quarter valued at $144,000. First Trust Advisors LP bought a new stake in shares of OPKO Health in the 4th quarter valued at $154,000. Finally, Xact Kapitalforvaltning AB bought a new stake in shares of OPKO Health in the 4th quarter valued at $179,000. Institutional investors own 23.38% of the company’s stock.

Several analysts have commented on OPK shares. Cantor Fitzgerald set a $20.00 target price on shares of OPKO Health and gave the company a “buy” rating in a research report on Thursday, March 1st. Zacks Investment Research cut shares of OPKO Health from a “hold” rating to a “sell” rating in a research report on Wednesday, March 7th. BidaskClub upgraded shares of OPKO Health from a “strong sell” rating to a “sell” rating in a research report on Friday, January 26th. ValuEngine cut shares of OPKO Health from a “sell” rating to a “strong sell” rating in a research report on Thursday, March 1st. Finally, JPMorgan Chase cut shares of OPKO Health from a “neutral” rating to an “underweight” rating and set a $7.00 target price for the company. in a research report on Friday, March 2nd. Four investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $11.29.

TRADEMARK VIOLATION NOTICE: “OPKO Health (OPK) Director Robert Scott Fishel Acquires 10,000 Shares” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.chaffeybreeze.com/2018/04/16/opko-health-opk-director-robert-scott-fishel-acquires-10000-shares.html.

About OPKO Health

OPKO Health, Inc, a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases.

Insider Buying and Selling by Quarter for OPKO Health (NASDAQ:OPK)

Receive News & Ratings for OPKO Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OPKO Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply